Physician profile
Daniel W Fox
NPI 1205820057
$2,361.09
in general payments reported to CMS, 2019-2025
16 companies · $73.26 in 2025
The $73.26 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $444 · 2020: $220 · 2021: $660 · 2022: $384 · 2023: $430 · 2024: $150 · 2025: $73.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $654.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $653.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $561.21 | 2019-2023 | Xarelto |
| Inari Medical, INC. | $415.74 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $337.10 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $201.72 | 2019-2022 | |
| Ucb, INC. | $200.97 | 2019-2023 | Briviact, Nayzilam |
| Novartis Pharmaceuticals Corporation | $143.34 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $121.82 | 2020-2023 | Xifaxan |
| Abbvie INC. | $114.91 | 2021-2023 | |
| Stryker Corporation | $73.26 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever |
| Merck Sharp & Dohme LLC | $57.78 | 2019-2020 | |
| Glaxosmithkline, LLC. | $27.01 | 2024 | Trelegy Ellipta |
| Astellas Pharma US INC | $26.49 | 2019 | |
| Vifor Pharma, INC. | $24.55 | 2019-2021 | |
| Melinta Therapeutics, LLC | $22.64 | 2019 | |
| Boston Scientific Corporation | $19.47 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $13.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.